Koninklijke Philips | PHG - Vertriebs- Und Verwaltungskosten





Vertriebs- Und Verwaltungskosten Veränderung Datum
Abbott USD 3.13B 125M 2025-12
Baxter International USD 761M 53M 2025-12
Becton, Dickinson and Co. USD 1.39B 27M 2025-12
Boston Scientific USD 1.83B 93M 2025-12
Danaher USD 2.03B 35M 2025-12
Demant DKK 6.09B 135M 2025-12
Dexcom USD 299.9M 31.5M 2025-12
Edwards Lifesciences USD 602.9M 88.3M 2025-12
Fresenius EUR 819M 143M 2025-12
General Electric Aerospace USD 1.58B 385M 2025-12
Getinge SEK 2.65B 452M 2024-12
Globus Medical USD 318.48M 4.88M 2025-12
GN Store Nord DKK 1.45B 41M 2025-12
Hitachi JPY 491.37B 24.02B 2025-12
Idexx Laboratories USD 275.68M 10.58M 2025-12
Insulet USD 331.4M 16.2M 2025-12
Integra LifeSciences USD 156.45M 12.6M 2025-12
Intuitive Surgical USD 687.1M 113.8M 2025-12
J&J USD 6.03B 719M 2026-03
Koninklijke Philips EUR 1.52B 142.19M 2025-12
Masimo USD 128M 11.6M 2025-12
Medtronic 2.97B 159M 2025-09
Philips EUR 1.31B 127M 2025-12
ResMed USD 278.4M 19.2M 2025-12
Smith & Nephew USD 1.42B 65M 2025-12
Steris USD 352.3M 2.6M 2025-12
Stryker USD 2.14B 150M 2025-12
Teleflex USD 222.37M 59.4M 2025-12
Terumo JPY 105.26B 7.38B 2025-12
Zimmer Biomet Holdings USD 855.7M 44.3M 2025-12